Novalact

Novalact is a Chilean biotech startup focused on the development probiotic bacteria to alleviate gastrointestinal illnesses. Because lactose intolerance is a common ailment, affecting around two thirds of the global human population, we are currently working in engineered probiotics that will bring freedom to those afflicted by this condition to enjoy life without restrictions.

Founders

Rodrigo Leyton

Francisco Arriaza